Extract

This study is being conducted to compare the safety and effectiveness of the investigational medication, LdT (Telbivudine) with Lamivudine, a drug currently approved by the US, European and Asian Health Authorities for the treatment of hepatitis B infection. The results for patients taking LdT will be compared to results for patients taking Lamivudine.

Inclusion criteria

• Chronic hepatitis B

Country

• Korea, Republic of
• Spain
• Thailand
• Turkey
• United Kingdom
• United States

Links

• ictrp
• nct